Founded in 1950 vips is the association of pharmaceutical companies operating in Switzerland, which represents the interests of its members in the relevant Swiss audiences. The focus is on the patient benefits, security of supply, to fair pricing, ensuring fair and pro-business environment, efficient processes in the management and protection of intellectual property.
Contact
vips – Association of Pharmaceutical Companies in Switzerland
Baarerstrasse 2
Postfach 7856
CH-6302 train
Phone: +41 41 727 67 80
Fax: +41 41 727 67 90
Email: info@vips.ch
Homepage: www.vips.ch
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss pharma market, featuring data snapshots, feature articles, exclusive interviews…
Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing attractiveness of Switzerland as a pharmaceutical investment destination. Attractive conditions…
Susanne Hoeppner, GM of Astellas Switzerland and board member of vips, discusses her key priorities, the culture of Swiss pharma, and the industry-wide push for faster approval times. Ms. Hoeppner,…
Not all impactful innovation involves the development of new chemical or biological entities, and the value of such innovation must be recognized in pricing processes argues Gebro Pharma Switzerland CEO…
Walter P. Hölzle, president of vips, discusses the current priorities of the association, the importance of innovation, and the challenges of the current pricing system. While growth is close to…
See our Cookie Privacy Policy Here
